All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group

OTC Proposals Need To Protect End-Users Better

Proposals to regulate over-the-counter derivatives do not go far enough in exempting corporate OTC end-users from margining or capital provisions, according to Jiro Okochi, ceo and co-founder of Reval, a derivative risk management provider.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree